Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arshad Majid

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
ISRN Neurology|March 1, 2014
Neuroprotection in stroke: past, present, and futureArshad Majid
Clinical Neuropharmacology|December 23, 2004
The potential of minocycline for neuroprotection in human neurologic diseaseDaniel Zemke, Arshad Majid
Brain Research|July 16, 2013
Role of histidine/histamine in carnosine-induced neuroprotection during ischemic brain damageOk-Nam Bae, Arshad Majid
Stroke|August 11, 2007
US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural resultsRishi Gupta, Osama Zaidat, Arshad Majid
Drug News & Perspectives|December 15, 2007
The mTOR pathway as a potential target for the development of therapies against neurological diseaseDaniel Zemke, Seema Azhar, Arshad Majid
The Annals of Pharmacotherapy|January 13, 2005
Minocycline has no effect on the fibrinolytic activity of alteplaseMuhammad U Farooq, Daniel Zemke, Arshad Majid
The Annals of Pharmacotherapy|May 3, 2022
Reply: Antiplatelet Use in Ischemic StrokeMarharyta Kamarova, Arshad Majid, Simon M Bell
Vascular Medicine (London, England)|January 29, 2005
Images in vascular medicine. An unusual presentation of cerebral sinus thrombosisChristopher C Glisson, Emile R Mohler, Arshad Majid
Frontiers in Neurology|March 2, 2011
Endovascular treatment of symptomatic intracranial atherosclerotic diseaseJody L Short, Arshad Majid, Syed I Hussain
Neuropharmacology|October 17, 2024
Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: Go broad or go narrow?Hala Kawa, Zubair Ahmed, Arshad Majid, et al.
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
ISRN Neurology|March 1, 2014
Neuroprotection in stroke: past, present, and futureArshad Majid
Clinical Neuropharmacology|December 23, 2004
The potential of minocycline for neuroprotection in human neurologic diseaseDaniel Zemke, Arshad Majid
Brain Research|July 16, 2013
Role of histidine/histamine in carnosine-induced neuroprotection during ischemic brain damageOk-Nam Bae, Arshad Majid
Stroke|August 11, 2007
US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural resultsRishi Gupta, Osama Zaidat, Arshad Majid
Drug News & Perspectives|December 15, 2007
The mTOR pathway as a potential target for the development of therapies against neurological diseaseDaniel Zemke, Seema Azhar, Arshad Majid
The Annals of Pharmacotherapy|January 13, 2005
Minocycline has no effect on the fibrinolytic activity of alteplaseMuhammad U Farooq, Daniel Zemke, Arshad Majid
The Annals of Pharmacotherapy|May 3, 2022
Reply: Antiplatelet Use in Ischemic StrokeMarharyta Kamarova, Arshad Majid, Simon M Bell
Vascular Medicine (London, England)|January 29, 2005
Images in vascular medicine. An unusual presentation of cerebral sinus thrombosisChristopher C Glisson, Emile R Mohler, Arshad Majid
Frontiers in Neurology|March 2, 2011
Endovascular treatment of symptomatic intracranial atherosclerotic diseaseJody L Short, Arshad Majid, Syed I Hussain
Neuropharmacology|October 17, 2024
Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: Go broad or go narrow?Hala Kawa, Zubair Ahmed, Arshad Majid, et al.
Pageof 13